title: (13)C NMR quantitative spectrometric data-activity relationship (QSDAR) models of steroids binding the aromatase enzyme.
abstract: Five quantitative spectroscopic data-activity relationships (QSDAR) models for 50 steroidal inhibitors binding to aromatase enzyme have been developed based on simulated (13)C nuclear magnetic resonance (NMR) data. Three of the models were based on comparative spectral analysis (CoSA), and the two other models were based on comparative structurally assigned spectral analysis (CoSASA). A CoSA QSDAR model based on five principal components had an explained variance (r(2)) of 0.78 and a leave-one-out (LOO) cross-validated variance (q(2)) of 0.71. A CoSASA model that used the assigned (13)C NMR chemical shifts from a steroidal backbone at five selected positions gave an r(2) of 0.75 and a q(2) of 0.66. The (13)C NMR chemical shifts from atoms in the steroid template position 9, 6, 3, and 7 each had correlations greater than 0.6 with the relative binding activity to the aromatase enzyme. All five QSDAR models had explained and cross-validated variances that were better than the explained and cross-validated variances from a five structural parameter quantitative structure-activity relationship (QSAR) model of the same compounds. QSAR modeling suffers from errors introduced by the assumptions and approximations used in partial charges, dielectric constants, and the molecular alignment process of one structural conformation. One postulated reason that the variances of QSDAR models are better than the QSAR models is that (13)C NMR spectral data, based on quantum mechanical principles, are more reflective of binding than the QSAR model's calculated electrostatic potentials and molecular alignment process. The QSDAR models provide a rapid, simple way to model the steroid inhibitor activity in relation to the aromatase enzyme.
authors.affiliation: Division of Chemistry, National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR 72079, USA. rbeger@nctr.fda.gov
authors.forename: R D
authors.initials: RD
authors.lastname: Beger
authors.forename: D A
authors.initials: DA
authors.lastname: Buzatu
authors.forename: J G
authors.initials: JG
authors.lastname: Wilkes
authors.forename: J O
authors.initials: JO
authors.lastname: Lay
mesh_terms: D001141:Aromatase / Q000378:metabolism*; D047072:Aromatase Inhibitors; D003198:Computer Simulation; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D021281:Quantitative Structure-Activity Relationship; D012044:Regression Analysis; D012985:Software Design; D013256:Steroids / Q000737:chemistry* / Q000378:metabolism*
chemical_list: D047072:Aromatase Inhibitors; D004791:Enzyme Inhibitors; D013256:Steroids; D001141:Aromatase